Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-11-000225
Filing Date
2011-04-14
Accepted
2011-04-14 16:36:08
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 QUANTRX 10-K DEC 31 2010 quantrx10kdec312010.htm 10-K 1322799
2 CERT OF DESIGNATION FOR SERIES B CONVERT PREF STOCK ex3-6.htm EX-3.6 95097
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 2685
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 14214
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 13608
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 6261
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 5456
  Complete submission text file 0001415889-11-000225.txt   1461351
Mailing Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901
Business Address 100 SOUTH MAIN STREET SUITE 300 DOYLESTOWN PA 18901 267-880-1595
QUANTRX BIOMEDICAL CORP (Filer) CIK: 0000820608 (see all company filings)

EIN.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17119 | Film No.: 11760021
SIC: 3841 Surgical & Medical Instruments & Apparatus